Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Struct Biol. 1996 Dec;6(6):830-7.

Sialidases: structures, biological significance and therapeutic potential.

Author information

School of Biology and Biochemistry, University of Bath, Claverton Down, UK.


The structure-based design of a potent inhibitor of the influenza-virus neuraminidase (sialidase) is one of the outstanding successes of rational drug design. Recent clinical trials of the drug have stimulated many companies to seek a share of the potentially huge flu market. Sialidases, however, are involved in the pathogenesis of a whole range of other diseases, so perhaps the knowledge and expertise gained from the influenza story can be used in the design of other drugs, given that they all share certain structural features.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center